In summary, FOXO1 regulation may contribute to the detrimental outcomes of the cardiac cells in diabetes, accelerating the development of DCM, one of the predominant cardiac difficulties in diabetic patients. This evidence concerns the gene FOXO1 and familial dilated cardiomyopathy.